Personalized Integrative Oncology: Targeted Approaches for Optimal Outcomes

描述（由申请人提供）：综合肿瘤学学会（SIO）第11届国际会议，题为“个性化综合肿瘤学：最佳结果的目标方法”，旨在批判性地审查有可能改善综合肿瘤学作为当代医疗保健选择的实践的最新研究进展。本次会议将重点传播综合肿瘤学研究的重要发现，这些研究采取有针对性的方法，包括基础和临床科学，以最终改善患者护理的结果。SIO 2014会议的首要目标是强调有针对性的综合肿瘤学研究、知识发展的独特轨迹及其在综合肿瘤学中的意义。 为期2天半的会议在休斯顿举行，由德克萨斯大学医学博士安德森癌症中心共同主办。2014年SIO会议计划包含三个主题演讲，将直接解决当前针对性综合肿瘤学的研究，包括：1）个性化综合肿瘤学在癌症预防，治疗和康复中的作用; 2）压力对癌症患者的影响;和3）睡眠障碍和癌症的交叉点。除了主题演讲，会议将包括：四个主持的全体小组计划涵盖：1）个性化的综合肿瘤学; 2）生活方式和表观遗传学的作用， 癌症的背景下; 3）与AAHPM联合会议，以解决有针对性的症状管理;和4）乳腺癌指南。会议还将有两个多学科综合肿瘤委员会;两个会前研讨会，重点关注与创新的综合肿瘤学相关的临床研究和临床实践;四个教学和体验研讨会;关于综合肿瘤学正念实践的公开讲座;和患者宣传和实习生流。在与靶向综合肿瘤学相关的各种主题中，包括临床试验，基础科学和研究方法，将向国家和国际研究社区的成员征集45个口头和多达80个海报演讲。会议的目的是：1）创建一个国际场所，研究人员，临床医生和患者倡导者可以讨论有关有针对性的综合肿瘤学研究和实践的现有证据，并提高他们对这一特定领域的优势和挑战的理解; 2）促进研究人员、卫生专业人员和患者倡导者之间的对话、合作和网络联系，促进未来的研究和知识，在综合肿瘤学领域使用有针对性的策略;和3）协助培训学员，早期职业调查员和病人倡导者创造，解读一项正在传播的循证综合肿瘤学研究。最终，我们希望从这次会议上获得的关于有针对性的综合肿瘤学的新知识和临床实践将改善综合肿瘤学家和从业者的患者护理结果。

DESCRIPTION (provided by applicant): The Society for Integrative Oncology (SIO) 11th International Conference, entitled "Personalized Integrative Oncology: Targeted Approach For Optimal Outcomes", aims to critically examine recent advances in research that have the potential to improve the practice of integrative oncology as a contemporary health care option. This conference will focus on disseminating important findings from integrative oncology research that are taking a targeted approach including both basic and clinical science, to ultimately improve the outcome of patient care. The overarching aim of the SIO 2014 conference is to highlight the unique trajectory of targeted integrative oncology research, knowledge development, and its implication in integrative oncology. The 2 and 1/2-day meeting is being held in Houston and is co-hosted by the University of Texas MD Anderson Cancer Center. The 2014 SIO conference program contains three keynote lectures that will directly address current research in targeted integrated oncology including the: 1) The role of personalized integrative oncology in the prevention, treatment and recovery from cancer; 2) The impact of stress on patients with cancer; and 3) The intersection of sleep disorders and cancer. In addition to keynote lectures, the conference will include: four moderated plenary panels are planned covering: 1) personalized integrative oncology; 2) the role of lifestyle and epigenetics in the context of cancer; 3) a joint session with AAHPM to tackle targeted symptom management; and 4) breast cancer guidelines. The conference will also have two multidisciplinary integrative tumor boards; two preconference workshops to focus on clinical research and clinical practice relevant to innovated integrative oncology; four didactic and experiential workshops; a public lecture on mindfulness practices in integrative oncology; and patient advocacy and trainee streams. Presentations of original research, in various topics related to targeted integrated oncology, including clinical trials, basic science, and research methodology, will be solicited from members of the national and international research communities for 45 oral and up to 80 poster presentations. The conference aims are to: 1) Create an international venue in which researchers, clinicians and patient advocates can discuss the current evidence regarding targeted integrative oncology research and practices and enhance their understanding the advantage and challenge of this particular field; 2) Foster dialogue, collaboration and networking among researchers, health professionals, and patient advocates, facilitating future research and knowledge using targeted strategies in the field of integrative oncology; and 3) Assist in the training of trainees, early career investigators and patient advocates in creating, interpreting an disseminating evidence-based integrative oncology research. Ultimately, it is our hope that the renewed knowledge and clinical practice on targeted integrative oncology obtained from this conference will improve the outcome of patient care by integrative oncologist and practitioners.